0001053369-14-000014.txt : 20140117 0001053369-14-000014.hdr.sgml : 20140117 20140117191322 ACCESSION NUMBER: 0001053369-14-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140113 FILED AS OF DATE: 20140117 DATE AS OF CHANGE: 20140117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/ CENTRAL INDEX KEY: 0001053369 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223542636 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 BUSINESS PHONE: 2017502646 MAIL ADDRESS: STREET 1: 165 LUDLOW AVENUE CITY: NORTHVALE STATE: NJ ZIP: 07647 FORMER COMPANY: FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/ DATE OF NAME CHANGE: 19980121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NARINE JEENARINE CENTRAL INDEX KEY: 0001465822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15697 FILM NUMBER: 14536331 MAIL ADDRESS: STREET 1: C/O EPIC PHARMA, LLC STREET 2: 227-15 NORTH CONDUIT AVENUE CITY: LAURELTON STATE: NY ZIP: 11413 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2014-01-13 0 0001053369 ELITE PHARMACEUTICALS INC /NV/ ELTP 0001465822 NARINE JEENARINE C/O EPIC PHARMA, LLC 227-15 NORTH CONDUIT AVENUE LAURELTON NY 11413 1 0 1 0 Common Stock 2014-01-13 4 S 0 805583 0.183 D 15341280 I By Epic Investments, LLC Common Stock 5957622 D Jeenarine Narine is an equity owner and executive officer of each of Epic Investments, LLC (EI)and Epic Pharma, LLC (EP), which is a 10% owner of the issuer, and also serves as a director of the issuer. Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI. Jeenarine Narine 2014-01-17